Robert Schreiber

View Scopus Profile

Willing to Mentor

Available to Mentor:

PhD/MSTP Students

82718

Citations

Research activity per year

If you made any changes in Pure these will be visible here soon.

301 Article
25 Review article
14 Editorial
6 Comment/debate
More

6 results

Filter

2018
Erratum: High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy (Cell (2018) 175(4) (1014–1030.e19), (S009286741831242X) (10.1016/j.cell.2018.09.030))
Gubin, M. M., Esaulova, E., Ward, J. P., Malkova, O. N., Runci, D., Wong, P., Noguchi, T., Arthur, C. D., Meng, W., Alspach, E., Medrano, R. F. V., Fronick, C., Fehlings, M., Newell, E. W., Fulton, R. S., Sheehan, K. C. F., Oh, S. T., Schreiber, R. D. & Artyomov, M. N., Nov 15 2018, In: Cell. 175, 5, p. 1443 1 p.
Research output: Contribution to journal › Comment/debate

Open Access
35 Scopus citations
Erratum to: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells (Nature Communications, (2017), 8, 1, (562), 10.1038/s41467-017-00627-z)
Fehlings, M., Simoni, Y., Penny, H. L., Becht, E., Loh, C. Y., Gubin, M. M., Ward, J. P., Wong, S. C., Schreiber, R. D. & Newell, E. W., Dec 1 2018, In: Nature communications. 9, 1, 3000.
Research output: Contribution to journal › Comment/debate

Open Access
1 Scopus citations
2005

Erratum: A critical function for type I interferons in cancer immunoediting (Nature Immunology (2005) vol. 6 (722-729))
Cunn, G. P., Bruce, A. T., Sheehan, K. C. F., Shankaran, V., Uppaluri, R., Bui, J. D., Diamond, M. S., Koebel, C. M., Arthur, C., White, J. M. & Schreiber, R. D., Aug 1 2005, In: Nature immunology. 6, 8, 1 p.
Research output: Contribution to journal › Comment/debate

Open Access
2000

Erratum: CD4⁺ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ (Proceedings of the National Academy of Sciences of the United States of America (July 20, 1999) 96 (8633-8638))
Mumberg, D., Monach, P. A., Wanderling, S., Philip, M., Toledano, A. Y., Schreiber, R. D. & Schreiber, H., Mar 16 2000, In: Proceedings of the National Academy of Sciences of the United States of America. 97, 5, 1 p.
Research output: Contribution to journal › Comment/debate
1999

Erratum: Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice (Journal of Immunology (1997) 158 (5692-5697))
Nakamoto, Y., Guidotti, L. G., Pasquetto, V., Schreiber, R. D. & Chisari, F. V., Jul 15 1999, In: Journal of Immunology. 163, 2, 1 p.
Research output: Contribution to journal › Comment/debate

1 Scopus citations
1988

Effect of combined anti-gamma interferon antibody and cyclosporine therapy on cardiac allograft survival in the rat
Didlake, R. H., Kim, E. K., Sheehan, K., Schreiber, R. D. & Kahan, B. D., Jan 1988, In: Transplantation. 45, 1, p. 222-223 2 p.
Research output: Contribution to journal › Comment/debate

19 Scopus citations

Robert Schreiber

Research output

Search results

Erratum: High-Dimensional Analysis Delineates Myeloid and Lymphoid Compartment Remodeling during Successful Immune-Checkpoint Cancer Therapy (Cell (2018) 175(4) (1014–1030.e19), (S009286741831242X) (10.1016/j.cell.2018.09.030))

Erratum to: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells (Nature Communications, (2017), 8, 1, (562), 10.1038/s41467-017-00627-z)

Erratum: A critical function for type I interferons in cancer immunoediting (Nature Immunology (2005) vol. 6 (722-729))

Erratum: CD4+ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ (Proceedings of the National Academy of Sciences of the United States of America (July 20, 1999) 96 (8633-8638))

Erratum: Differential target cell sensitivity to CTL-activated death pathways in hepatitis B virus transgenic mice (Journal of Immunology (1997) 158 (5692-5697))

Effect of combined anti-gamma interferon antibody and cyclosporine therapy on cardiac allograft survival in the rat

Erratum: CD4⁺ T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-γ (Proceedings of the National Academy of Sciences of the United States of America (July 20, 1999) 96 (8633-8638))